Medizinische Universität Graz - Research portal

• Go directly to the nagivation.
• Go directly to the content.

• Print view.
• German.
• Contact.
• Data entry.
• Start.
• Open Access.

European network of paediatric Hodgkin´s lymphoma- European-wide organisation of quality controlled treatment (Paediaric Hodgkin network)

Abstract

Build on the experience from national trials for paediatric Hodgkin's lymphoma (PHL) experts from 12 EU countries decided on a common protocol to individualise PHL treatment.

The general objective of this proposal is to ensure a high-quality teatment for all affected patients from paediatric Hodgkin's lymphoma independent of their social or geographical origin by establishing a shared case management and expert system using a medical image and communication network. Aim of the high-quality treatment planning algorithm is to achieve high rates for event-free survival with the least necessary treatment toxicity in every child.

Keywords

nuclear medicine

Local Subprojectlead:

Aigner Reingard

Duration:

01.08.2008-31.07.2011

Programme:

EU (FP-6)

Type of Research

applied research

Staff

Aigner, Reingard, Project Leader

MUG Research Units

Division of Nuclear Medicine

Project partners

Fundacion Vasca de Innovacion e Investigacion Sanitarias-BIOEF, Spain

Jagiellonian University Medical College, Poland

Karolinska University Hospital, Sweden

Martin-Luther Universität Halle-Wittenberg, Germany

Medizinische Universität Leipzig, Germany

NHS Lothian Health Board, United Kingdom

Our Lady`s Children Hospital, Ireland

Rigshospitalet University of Copenhagen, Denmark

Rikshospitalet–Radiumhospitalet Hospital Trust, Norway

St. Elisabeth Oncological Institute, Slovakia

University Children`s Hospital of Krakow, Poland

University Hospital of La Paz, Spain

University Hospitals and Clinics Motol, Czech Republic

, Poland

, France

Funded by

Europäische Kommission, Rue de la Loi, Brussels, Belgium